Clinical trials: Smoking Cessation, completed
Smoking Cessation
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation
The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo for smoking cessation.
- Trial name
- NCT00141167
- Testing
- varenicline
- Where
- 10 sites in South Korea, Taiwan
- Volunteers
- 250 people
- Sponsor
- Pfizer
Cigarette Smoking
iQuit Mindfully: Text Messaging for Smoking Cessation
The purpose of this study is to investigate text messaging as a way to enhance mindfulness-based treatment for smoking cessation.
- Trial name
- NCT03029819
- Testing
- Mindfulness-based Addiction Treatment, iQuit Mindfully, Self-Help guide
- Where
- United States
- Volunteers
- 72 people
- Sponsor
- Georgia State University
Acne Vulgaris, Allergic Rhinitis
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
- Conditions
- Acne Vulgaris, Allergic Rhinitis, Anxiety, Asthma
- Trial name
- NCT01050465
- Testing
- health information prescription
- Volunteers
- 907 people, healthy volunteers welcome
- Sponsor
- University of Missouri-Columbia
Alcohol Drinking
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
The purpose of this study is to examine the effect of smoking cessation medications on alcohol drinking. Effect of 2mg/day, 1mg/day, placebo varenicline was evaluated.
- Trial name
- NCT00580645
- Testing
- varenicline
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Yale University
Nicotine Dependence
Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity
Background: Smoking is a difficult habit to quit, and some people find it more difficult to quit than others do. Nicotine is the substance in cigarettes that makes smoking so addictive.
- Trial name
- NCT01867411
- Where
- United States
- Volunteers
- 159 people, healthy volunteers welcome
- Sponsor
- National Institute on Drug Abuse (NIDA)
Tobacco Use, Tobacco Smoking
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)
Due to the pandemic, this study was modified from a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention to a feasibility and acceptability test of our…
- Conditions
- Tobacco Use, Tobacco Smoking, Tobacco Use Cessation, Tobacco Use Disorder
- Trial name
- PTSC-S (NCT03873337)
- Testing
- Persistence Targeted Smoking Cessation in SMI (PTSC-S), Nicotine patch
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- Rutgers, The State University of New Jersey
Smoking Cessation
Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
This study will investigate the efficacy of EVT 302, a potent and selective inhibitor of Monoamine Oxidase - B, in improving quit rates in chronic cigarette smokers who are motivated to quit smoking.
- Trial name
- NCT00738595
- Testing
- EVT 302, EVT 302 plus open label Nicotine replacement
- Where
- 9 sites in Germany
- Volunteers
- 400 people
- Sponsor
- Evotec Neurosciences GmbH
Nicotine Dependence, Major Depressive Disorder
Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
Persons who struggle with depression smoke at high rates and experience low quit rates in treatment. The best way to improve cessation treatment for this underserved population remains unknown.
- Trial name
- NCT02378714
- Testing
- Varenicline, BASC, Standard treatment
- Where
- 2 sites in United States
- Volunteers
- 300 people
- Sponsor
- Northwestern University
Cigarette Smoking
The Effectiveness of Smoking Cessation Guidelines in the Emergency Department
Although 78% of smokers report that a health professional has previously advised them to quit smoking, most smokers are not advised to stop smoking or offered assistance with smoking cessation during a given ED visit.
- Trial name
- NCT00756704
- Testing
- Smoking cessation guideline implementation
- Where
- 2 sites in United States
- Volunteers
- 789 people, healthy volunteers welcome
- Sponsor
- University of Iowa
Tobacco Dependence
Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation
The purpose of this study is to test whether the addition of a nicotine patch to varenicline increases smoking cessation success rate and whether the combination is safe.
- Trial name
- NCT01444131
- Testing
- Varenicline, Nicotine Patch
- Where
- 7 sites in South Africa
- Volunteers
- 446 people
- Sponsor
- University of Stellenbosch
Smoking Cessation
Genetically Informed Smoking Cessation Trial
The investigators' goal is to identify the most appropriate smoking cessation treatments for smokers based on genetic information. Smokers try to quit smoking but relapses are common.
- Trial name
- GISC (NCT02351167)
- Testing
- Combination NRT (Nicotine patch, Nicotine lozenge), Varenicline, Intensive smoking counseling
- Where
- United States
- Volunteers
- 822 people, healthy volunteers welcome
- Sponsor
- Washington University School of Medicine
Smoking Cessation
A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
The purpose of this study is to evaluate the pharmacokinetics and safety of oral administration of BR9003 compared with BR9003A in healthy adult subjects
- Trial name
- NCT04846998
- Testing
- BR9003, BR9003A
- Where
- South Korea
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Boryung Pharmaceutical Co., Ltd
Tobacco Dependence, Smoking Cessation
Tailoring Varenicline to Individual Needs (TVIN Study)
Varenicline is a partial nicotinic agonist which acts on alpha4 beta2 nicotinic receptors. It is presumed to alleviate withdrawal discomfort, but also to diminish rewarding effects of cigarettes.
- Trial name
- TVIN (NCT01206010)
- Testing
- Varenicline
- Where
- United Kingdom
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Queen Mary University of London
Tobacco Use Disorder
Innovative Interventions for Smoking Cessation
The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only and very low nicotine content cigarette only…
- Trial name
- NCT01050569
- Testing
- Nicotine Patch, VLNC Cigarette, VLNC Cigarette Plus Nicotine Patch
- Where
- 2 sites in United States
- Volunteers
- 235 people, healthy volunteers welcome
- Sponsor
- University of Minnesota
Smoking Cessation, Lifestyle Risk Reduction
Empower Korean Families to End Tobacco Use & Smoking Exposure
The goals of the study are to develop a culturally and linguistically appropriate intervention to promote smoking cessation and reduce secondhand smoke exposure for Korean Americans using a family-based intervention approach…
- Trial name
- NCT04079569
- Testing
- Tobacco, Healthy Living
- Where
- United States
- Volunteers
- 112 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Secondhand Smoke Exposure, Respiratory Illness
Secondhand Smoke Exposure Reduction Among Young Children in China
Second hand smoking (SHS) is a health hazard to infants and children, in whom it is associated with lower respiratory tract infections, wheezing, cough, middle ear infections and sudden infant death syndrome.
- Conditions
- Secondhand Smoke Exposure, Respiratory Illness, Smoking Cessation
- Trial name
- China SHARE (NCT00995254)
- Testing
- SHI counseling
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Boston University
Tobacco Use
Strategies to Help Adult ED Patients Quit Smoking
The purpose of this study is to determine whether a brief, focused intervention in the hospital emergency department is effective in helping adults quit smoking.
- Trial name
- NCT00297466
- Testing
- transdermal nicotine patches, Motivational interview
- Where
- United States
- Volunteers
- 336 people
- Sponsor
- National Institute on Drug Abuse (NIDA)
Pharmacokinetics, Bioavailability
An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation
1. To estimate the absorption of a single oral dose of a controlled release varenicline tablet under fed and fasted conditions. 2.
- Conditions
- Pharmacokinetics, Bioavailability, Smoking Cessation
- Trial name
- NCT00731562
- Testing
- Varenicline Tartrate Controlled Release
- Where
- 2 sites in United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Pfizer
Tobacco Use Cessation, Smoking Behaviors
Interventions to Help More Low-income Smokers Quit
In a Hybrid Type 2 randomized trial, 1,980 low-income smokers from nine states with high smoking prevalence will be recruited from 2-1-1 helplines to receive either current standard practice (Quitline) or expanded services…
- Conditions
- Tobacco Use Cessation, Smoking Behaviors, Health Disparity
- Trial name
- SFH (NCT04311983)
- Testing
- Tobacco Quitline, Smoke Free Home
- Where
- United States
- Volunteers
- 1,973 people, healthy volunteers welcome
- Sponsor
- Washington University School of Medicine
Smoking Cessation
PMCAN for Smokers at Smoking Hotspots
Background: Many smokers cannot quit due to nicotine withdrawal symptoms, which peak at the first week of abstinence. Proactive recruitment of smokers is needed as most smokers do not seek smoking cessation (SC) services.
- Trial name
- NCT02935231
- Testing
- Nicotine Replacement Therapy (NRT), Minimal Cessation Advice (MCA), Health warning leaflet
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- The University of Hong Kong
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.